Landscape Capital Management, L.L.C. Fulcrum Therapeutics, Inc. Transaction History

Landscape Capital Management, L.L.C.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$5.98 - $9.31 $504,030 - $784,702	-84,286 Reduced 88.93%	10,489 $65,000
Q1 2024 May 09, 2024	BUY	$6.7 - $12.0 $201,140 - $360,252	30,021 Added 46.36%	94,775 $894,000
Q4 2023 Feb 05, 2024	BUY	$3.18 - $6.86 $116,076 - $250,403	36,502 Added 129.2%	64,754 $437,000
Q3 2023 Nov 08, 2023	BUY	$3.25 - $6.08 $91,819 - $171,772	28,252 New	28,252 $125,000
Q1 2023 May 10, 2023	BUY	$2.83 - $13.99 $7,431 - $36,737	2,626 Added 23.63%	13,740 $39,000
Q4 2022 Feb 09, 2023	BUY	$5.01 - $8.35 $55,681 - $92,801	11,114 New	11,114 $80,000

150

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $237M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Landscape Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Landscape Capital Management, L.L.C. with notifications on news.